trending Market Intelligence /marketintelligence/en/news-insights/trending/47oZk5TlGlfu3C-_bO4LHg2 content esgSubNav
In This List

Aeglea BioTherapeutics prices $12.3M common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Aeglea BioTherapeutics prices $12.3M common stock offering

Aeglea BioTherapeutics Inc. priced an underwritten public offering of 3 million shares at $4.10 apiece to raise $12.3 million in gross proceeds.

The offering is expected to close June 9 with JonesTrading Institutional Services LLC acting as the sole book runner. The underwriter has an option to purchase up to an additional 450,000 of the shares offered.

Aeglea plans to use the net proceeds to fund its research and development product candidates and for other general corporate purposes.